We are live on
!
Find out more
FC
Forte Capital Portfolio holdings
AUM
$930M
Turnover
5.33%
1-Year Est. Return
24.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+24.11%
3 Year Est. Return
+98.33%
5 Year Est. Return
+137.98%
10 Year Est. Return
+353.1%
AUM
$256M
AUM Growth
+$16.9M
(+7.1%)
Cap. Flow
+$8.81M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
38.91%
Holding
88
New
3
Increased
52
Reduced
29
Closed
1
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSBC
HSBC
|
+$1.04M |
| 2 |
Philip Morris
PM
|
+$1.02M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$643K |
| 4 |
Bank of New York Mellon
BNY
|
+$619K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$522K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flagstar Bank National Association
FLG
|
+$354K |
| 2 |
Verizon
VZ
|
+$132K |
| 3 |
TotalEnergies
TTE
|
+$101K |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$91K |
| 5 |
IBM
IBM
|
+$90.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 32.58% |
| 2 | Technology | 21.01% |
| 3 | Financials | 13.3% |
| 4 | Healthcare | 11.35% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ESRX
26
DELISTED
Express Scripts Holding Company
ESRX
| $3.3M | 1.29% |
42,741
-975
| -2% | -$73.2K |
2014 Q3
15 quarters
|
|
27
CVS Health
CVS
$118B
| $3.28M | 1.28% |
51,033
+1,917
| +4% | +$126K |
2014 Q3
15 quarters
|
|
28
TC Energy
TRP
$62.2B
| $3.03M | 1.18% |
70,163
+4,278
| +6% | +$182K |
2014 Q3
15 quarters
|
|
29
Affiliated Managers Group
AMG
$9.91B
| $3M | 1.17% |
20,147
+575
| +3% | +$94.8K |
2014 Q3
15 quarters
|
|
30
Schwab US Large- Cap ETF
SCHX
$74.6B
| $2.89M | 1.13% |
267,102
+8,670
| +3% | +$93.5K |
2016 Q1
9 quarters
|
|
31
Bank OZK
OZK
$5B
| $2.86M | 1.12% |
63,525
+5,091
| +9% | +$243K |
2015 Q2
12 quarters
|
|
32
Monro
MNRO
$449M
| $2.77M | 1.08% |
47,594
| – | – |
2014 Q3
15 quarters
|
|
33
Jacobs Solutions
J
$16.6B
| $2.58M | 1.01% |
49,055
+3,827
| +8% | +$197K |
2014 Q3
15 quarters
|
|
34
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.7B
| $2.49M | 0.97% |
14,163
-174
| -1% | -$29.8K |
2014 Q3
15 quarters
|
|
35
Johnson & Johnson
JNJ
$610B
| $2.41M | 0.94% |
19,847
+507
| +3% | +$63.3K |
2014 Q3
15 quarters
|
|
36
Vanguard Morningstar Growth ETF
VUG
$232B
| $2.36M | 0.92% |
94,386
-1,296
| -1% | -$31.8K |
2014 Q3
15 quarters
|
|
37
Dollar Tree
DLTR
$23.3B
| $2.36M | 0.92% |
27,722
+135
| +0.5% | +$12.4K |
2014 Q3
15 quarters
|
|
38
Gilead Sciences
GILD
$195B
| $2.34M | 0.91% |
32,975
-180
| -0.5% | -$12.7K |
2014 Q3
15 quarters
|
|
39
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $2.28M | 0.89% |
124,524
+3,573
| +3% | +$64.6K |
2016 Q1
9 quarters
|
|
40
Cognizant
CTSH
$29.6B
| $2.26M | 0.88% |
28,560
-65
| -0.2% | -$5.11K |
2014 Q3
15 quarters
|
|
41
Core Laboratories
CLB
$449M
| $2.14M | 0.84% |
16,956
+2,570
| +18% | +$313K |
2014 Q3
15 quarters
|
|
42
Paychex
PAYX
$39.4B
| $2.13M | 0.83% |
31,158
-452
| -1% | -$29.2K |
2014 Q3
15 quarters
|
|
43
ExxonMobil
XOM
$718B
| $2.13M | 0.83% |
25,686
+2,368
| +10% | +$189K |
2014 Q3
15 quarters
|
|
44
Merck
MRK
$358B
| $1.88M | 0.73% |
32,383
-521
| -2% | -$29.4K |
2014 Q3
15 quarters
|
|
45
AT&T
T
$161B
| $1.79M | 0.7% |
73,915
+1,435
| +2% | +$36K |
2014 Q3
15 quarters
|
|
46
JPMorgan Chase
JPM
$891B
| $1.71M | 0.67% |
16,434
+20
| +0.1% | +$2.19K |
2014 Q3
15 quarters
|
|
|
47
Verizon
VZ
$184B
| $1.7M | 0.67% |
33,850
-2,718
| -7% | -$132K |
2014 Q3
15 quarters
|
|
48
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
| $1.63M | 0.64% |
64,442
+1,958
| +3% | +$49.5K |
2016 Q1
9 quarters
|
|
49
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $1.63M | 0.64% |
31,418
-946
| -3% | -$49K |
2014 Q3
15 quarters
|
|
50
AbbVie
ABBV
$501B
| $1.61M | 0.63% |
17,436
+2,195
| +14% | +$214K |
2014 Q3
15 quarters
|
|
Similar funds
PP
SC
CCM
BWA
SAF
NRD
CCP
ECM
Forte Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Forte Capital held 88 positions worth $256M, up 7.1% from $239M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Forte Capital deployed $8.81M of net new capital in Q2 2018, opening 3 new positions and adding to 52 existing holdings. Its largest new stake was HSBC: 22,713 shares worth $1.01M.
By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 34% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Verizon, an estimated $132K trimmed.
- Forte Capital's largest Q2 2018 buy was HSBC: 22,713 shares worth $1.01M.
- Forte Capital added most to Vanguard Short-Term Bond ETF in Q2 2018, an estimated $643K increase.
- Forte Capital's biggest Q2 2018 reduction was Verizon, cutting an estimated $132K.
- Forte Capital fully exited Flagstar Bank National Association in Q2 2018, selling an estimated $354K.
- Forte Capital's ten largest holdings make up 39% of its $256M portfolio in Q2 2018.
- Forte Capital opened 3 new positions and closed 1 in Q2 2018.
- Forte Capital's portfolio value rose 7.1% quarter-over-quarter to $256M.
Based on Forte Capital's 13F filing for Q2 2018, filed 13 Jul 2018.